Skip to main content

Thalidomide

Volume 498: debated on Wednesday 28 October 2009

To ask the Secretary of State for Health whether his Department has funded research into the potential effectiveness of the use of Thalidomide in the treatment of certain illnesses. (295438)

I am told that the Department has not funded research into the effectiveness of thalidomide in the treatment of illnesses.

Thalidomide was licensed in June 2008 for the treatment of multiple myeloma or for those ineligible for high dose chemotherapy. Thalidomide UK and other stakeholders both here and in Europe were consulted throughout the licensing process and I understand that they have acknowledged the benefits of thalidomide for the treatment of multiple myeloma.